United States · FDA National Drug Code directory
Balfaxar
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68982-261_5be10bd2-a785-7f3b-0d28-d066cd5f7d24
- Product NDC
- 68982-261
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Prothrombin Complex Concentrate (Human)
- Labeler
- Octapharma USA Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20231130
- Source listing expiry
- 20261231
Source-listed ingredients
- COAGULATION FACTOR IX HUMAN — 25.5 [iU]/mL
- PROTHROMBIN — 26 [iU]/mL
- COAGULATION FACTOR VII HUMAN — 16.5 [iU]/mL
- COAGULATION FACTOR X HUMAN — 24 [iU]/mL
- PROTEIN C — 22 [iU]/mL
- PROTEIN S HUMAN — 22 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (68982-261-01) / 20 mL in 1 VIAL, GLASS (68982-261-81) · 68982-261-01
- 1 VIAL, GLASS in 1 CARTON (68982-261-02) / 40 mL in 1 VIAL, GLASS (68982-261-82) · 68982-261-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →